Medifast Diet Review -Based on Customer Experience

Fri, 28 Nov 2008 09:29:53 GMT

Medifast Diet Review -Based on Customer Experience. Here is a review of the popular Medifast Diet as well as how to get a discount on your meals.

Motorola offers durable smart phones for business wireless LANs

Tue, 11 Nov 2008 05:00:00 GMT

Motorola today announced two durable smart phones that operate over wireless LANs and are focused on retail, health care and other business customers.

Exelixis lays off 78 people (at bizjournals.com)

Sat, 08 Nov 2008 12:05:30 GMT

Exelixis will take a $3.3 million restructuring-related charge in the fourth quarter, related to one-time “termination benefits.” The restructuring plan will be completed during the first quarter of 2009.

Health Net tells CEO to focus on strategy, COO to handle operatio...

Tue, 04 Nov 2008 17:38:53 GMT

The board of directors at Health Net Inc. has held its own election, and cast a decidedly negative vote on the Los Angeles-based health plan’s direction. The changes, affecting several top officers, came down the same day the company announced disappointing third-quarter results.

CTS Corporation Q3 2008 Earnings Call Transcript

Tue, 04 Nov 2008 04:27:13 GMT

CTS Corporation (CTS)Q3 2008 Earnings CallComplete Story

Intel Capital puts $20M in Chinese solar business

Tue, 28 Oct 2008 19:26:59 GMT

Intel Capital, the global investment arm of Intel Corp., said it made three new investments in China, including a $20 million investment in thin-film solar energy provider Trony Solar Holdings Co.

Nektar sells some assets to Novartis for $115M (at bizjournals.co...

Tue, 21 Oct 2008 16:05:09 GMT

San Carlos-based Nektar (NASDAQ: NKTR), led by CEO Howard Robin, will sell powder and liquid drug formulations, capital equipment and factory leases, along with 140 Nektar workers. Novartis (NYSE: NVS) also is buying some intellectual property in the deal.

In Bristol-ImClone Showdown, Watch Wilmington

Tue, 05 Aug 2008 09:11:40 GMT

Whether Carl Icahn is able to pry more money out of the deal hinges on Delaware's tricky takeover rules.

St. Joseph's NICU Patients Benefit from Improved Safety of the Ti...

Tue, 22 Jul 2008 10:12:42 GMT

PR: Timeless Medical Systems and St. Joseph's Health Care, London announced today the results of their implementation of the Timeless Mother's Own Milk System (MOMS)™. The Mother's Own Milk System (MOMS) has been in use at St. Joseph's Hospital NICU located in London, Ontario,

Pfizer and the State of Statins (at CNBC)

Mon, 23 Jun 2008 15:15:32 GMT

As much as I tried to disconnect during my vacation last week, I couldn't escape the ubiquitous presence of pharmaceuticals in our everyday lives...

SonoSite Appoints New CFO

Mon, 12 May 2008 02:15:15 GMT

Bernard J. Pitz named Senior Vice President and CFOMike Schuh to take new position within companyBOTHELL, WA - May 12, 2008 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, announced that Bernard J. Pitz is joining the company today

AstraZeneca: Symbicort combination patent for COPD revoked (at Ma...

Tue, 06 May 2008 11:38:27 GMT

LONDON (MarketWatch) -- Anglo-Swedish drug maker AstraZeneca [ss: uk:azn] said Tuesday that that European Patent Office has revoked one of two combination patents covering the use of AstraZeneca's Symbicort drug to treat chronic obstructive pulmonary disease. The patent was revoked following an

Neurogen names two C-level execs

Fri, 25 Apr 2008 14:44:49 GMT

Neurogen Corp., a drug developer creating treatments for insomnia, anxiety and Parkinson's disease, among other maladies, named two biotech execs to new C-level positions. Branford, Conn.-based small-molecule biotech company Neurogen (Nasdaq: NRGN) said Dr.

Merck Tosses Another PR Problem On The Pile (at Investopedia)

Wed, 02 Apr 2008 20:46:49 GMT

Merck (NYSE:MRK) needed was another public relations crisis. But unfortunately for shareholders that appears to be exactly what Merck has on its hands.

Is Wyeth Waking Up? (at Barron's Online)

Wed, 02 Apr 2008 16:55:00 GMT

The index of 21 pharmaceutical stocks gained 1.51% on Tuesday and Wyeth gained 2.26%. Recently, Wyeth shares were giving back some of those gains and trading lower at about $41.82.

Big Pharma, Big Biotech: big problems (at CNNMoney.com)

Fri, 01 Feb 2008 19:44:00 GMT

After a slew of mixed earnings from the some of the largest pharmaceutical and biotech companies, the industry faces impotent pipelines going forward.

Matrox Imaging - News & Events - Latest Press Releases

October 3, 2000, Montreal, Canada - Introduced this month at the AIA Vision Show West 2000 in San Jose, California, Matrox Imaging's GenesisPlus vision processor board delivers impressive computing power and memory bandwidth of up to 1 gigabyte/sec.

First Responders Say Advanced Technology Critical for Effectivene...

Key survey findings reveal a strong demand for technology solutions that provide advanced situational awareness to first responders, improve incident coordination, and streamline emergency response.

Genentech investments sour with market crash

Mon, 27 Oct 2008 04:00:00 GMT

The South San Francisco company took a $67 million third-quarter charge for impaired investments, primarily tied to preferred stock in Fannie Mae, Freddie Mac and Lehman Brothers Holdings Inc.

Earnings Outlook: Lower profit but higher sales seen from Scherin...

Fri, 17 Oct 2008 20:59:00 GMT

Schering-Plough Corp. is expected to report markedly lower earnings on Tuesday compared to last year's period, largely due to various accounting items, but sales should come in dramatically higher, thanks to its recent acquisition of Organon.

Intel to partner with DreamWorks on 3-D

Tue, 08 Jul 2008 16:25:39 GMT

Santa Clara-based Intel (Nasdaq: INTC) said it will supply "the latest high-performance processing technologies, including future chips with multiple processing cores," and its software engineers "will help to optimize DreamWorks' applications for these advanced processors."

FDA withholds approval of Merck cholesterol drug (at MarketWatch)

Tue, 29 Apr 2008 00:35:00 GMT

SAN FRANCISCO (MarketWatch) -- Merck & Co. said Monday that the Food and Drug Administration denied approval of its Cordaptive cholesterol drug, dealing a stinging blow to the pharmaceutical giant as it struggles to find a new direction and send a positive signal to investors.

Merck gets FDA not approvable letter for cholestrol drug (at Mark...

Mon, 28 Apr 2008 22:46:31 GMT

SAN FRANCISCO (MarketWatch) -- Merck & Co. said late Monday it received a Not Approvable action letter from the Food and Drug Administration for MK-0524A for the treatment of primary hypercholesterolemia or mixed dyslipidemia. We plan to meet with the FDA and to submit additional information to

Earnings Outlook: Pfizer seen as reporting higher earnings, but l...

Thu, 16 Oct 2008 23:08:00 GMT

BOSTON (MarketWatch) - Pfizer Inc. is expected to report markedly higher third-quarter earnings, due primarily to massive charges taken during last year's period, but relatively flat sales.

SurModics Acquires CodeLink(TM) Activated Slide Business (Busines...

Tue, 30 Sep 2008 20:00:00 GMT

SurModics Acquires CodeLink(TM) Activated Slide Business. - EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq: SRDX - News), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today the acquisition of the CodeLink™ Activated

Zibb.com: Motorola Incorporated (Industry News & Blogs)